Showing results (1471-1480 of 1,659) with videos related to

Sort By:
Pageof 166
Blood Cancer Journal|August 1, 2025
Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myelomaMobina Golmohammadi, Shahzad Raza, Maram Albayyadhi, et al.
The Review of Scientific Instruments|September 4, 2012
Cryogenic linear Paul trap for cold highly charged ion experimentsM Schwarz, O O Versolato, A Windberger, et al.
Nature Communications|January 20, 2024
Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assemblyEmilie Murigneux, Laurent Softic, Corentin Aubé, et al.
Sleep|February 20, 2021
Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson's diseaseChristopher E J Doppler, Julia A M Smit, Maximilian Hommelsen, et al.
The Journal of Cell Biology|June 12, 2013
RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage responseSara L Poulsen, Rebecca K Hansen, Sebastian A Wagner, et al.
International Journal of Cancer|December 26, 2015
HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cellsHaiyan Xiao, Jing Jiao, Liqing Wang, et al.
Journal of Medicinal Chemistry|June 3, 2017
Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap GroupsViktoria Krieger, Alexandra Hamacher, Christoph G W Gertzen, et al.
Cerebral Cortex Communications|December 19, 2022
Local networks from different parts of the human cerebral cortex generate and share the same population dynamicAlex Willumsen, Jens Midtgaard, Bo Jespersen, et al.
Science (New York, N.Y.)|July 24, 2021
A DNA repair pathway can regulate transcriptional noise to promote cell fate transitionsRavi V Desai, Xinyue Chen, Benjamin Martin, et al.
Clinical Epigenetics|August 2, 2018
Effects of novel HDAC inhibitors on urothelial carcinoma cellsAline Kaletsch, Maria Pinkerneil, Michèle J Hoffmann, et al.
Pageof 166